Recently, antibiotic resistance has become an increasing threat to public health, and new novel antibiotics are needed more than ever. The σE pathway represents one promising target in Gram-negative bacteria, where it facilitates the upregulation of outer membrane proteins in response to membrane damage. Using a compound known to weakly inhibit the pathway, analogues have been developed as attempts at optimization, and their molecular targets will be identified via an in vivo click conjugation protocol.